Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

NERV — Minerva Neurosciences, Inc. SEC Filings | FilingIndex

NERVNasdaq

Minerva Neurosciences, Inc.

Pharmaceutical Preparations · MA · CIK 1598646

Minerva Neurosciences, Inc. develops and seeks regulatory approval for roluperidone and other potential product candidates

+ Watch View on EDGAR ↗

$210M

Market cap

$5.55

Last close

+2.2%

1D

+27.6%

5D

221K

Volume

Price · last 40 sessions-12.3%

May 4L $4.11 · H $6.33Jun 30

234

Total filings

Jun 4, 2026

Last filing

12/31

Fiscal year end

All 8-K · 127 10-Q · 36 SC 13G · 13 DEF 14A · 12 10-K · 12 DEFA14A · 11 10-K/A · 5 424B5 · 5

DEFA14ADEFA14AApr 23, 2026 DEFA14ADEFA14AOct 22, 2024 DEFA14ADEFA14AAug 15, 2023 DEFA14ADEFA14AApr 26, 2022 DEFA14ADEFA14AApr 30, 2021 DEFA14A

Similar companies

Comparable business profile · signals at a glance

ANROAlto Neuroscience, Inc.$753.5M-6.0%ACIUAC Immune SA$235.1M-10.5%BYSIBeyondSpring Inc.$64.6M-2.2%ASRTAssertio Holdings, Inc.$151.7M+0.1%BLTEBELITE BIO, INC

DEFA14A

Apr 28, 2020

DEFA14ADEFA14AApr 17, 2019

DEFA14ADEFA14AApr 24, 2018

DEFA14ADEFA14AApr 18, 2017

DEFA14ADEFA14AApr 29, 2016

DEFA14ANOTICE AND ACCESS CARDApr 30, 2015

$5.5B

-0.4%

ACRSAclaris Therapeutics, Inc.$603.3M+5.4%